medigraphic.com

2019, Number 3

<< Back Next >>

Rev Clin Esc Med 2019; 9 (3)

Síndrome Serotoninérgico

Mora AM, Vega CJC, Vásquez JS, Arias DF

Language: Spanish
References: 17
Page: 14-19
PDF size: 527.27 Kb.


ABSTRACT

Serotonin syndrome is a potentially lethal adverse drug reaction that results from the therapeutic use of some drug, intentional overdose or involuntary drug interactions. Therefore, the syndrome is a predictable consequence of excess serotonergic agonism of central nervous system and of peripheral nervous system. This serotonin excess produces a spectrum of findings and clinical manifestations range from mild to severe symptoms that threaten the lives of patients. It is extremely important to recognize the syndrome for early diagnosis and the most appropriate approach, as it has significant impact on prognosis. In this document we review the most important aspects of the syndrome, its diagnosis and treatment.


REFERENCES

  1. Thanacoody R. Serotonin syndrome: Complications of poisoning. Medicine. 2012; 40: 63-64. doi: https://doi.org/10.1016/j.mpmed.2011.11.005

  2. Boyer EW Traub SJ Grayzel J. Serotonin syndrome (serotonin toxicity). UpToDate. 2018. doi: https:// www.uptodate.com/contents/serotonin-syndromeserotonin- toxicity

  3. Ternaux JP. Serotonin Syndrome. Encyclopedia of Movement Disorders. 2010; 108-111. doi: https://doi. org/10.1016/B978-0-12-374105-9.00421-4

  4. Thanacoody R. Serotonin syndrome: Complications of poisoning. Medicine. 2016; 44: 95-96. doi: https://doi.org/10.1016/j.mpmed.2015.11.009

  5. Tormoehlen LM. Rusyniak DE. Neuroleptic malignant syndrome and serotonin syndrome. Handbook of Clinical Neurology. 2018; 157: 663-675. doi: https:// doi.org/10.1016/B978-0-444-64074-1.00039-2

  6. Gummin DD Mowry JB Spyker DA Brooks DE Osterthaler KM Banner W. 2017 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 35th Annual Report. Clinical Toxicology Journal. 2018; 56: 1213- 1415 doi: https://doi.org/10.1080/15563650.2018.15 33727

  7. Boyer EW Shannon M. The Serotonin Syndrome. Current concepts. N Engl J Med. 2005; 352:1112- 1120. doi: 10.1056/NEJMra041867

  8. Ganetsky M Traub SJ Burns MM Grayzel J (2018). Selective serotonin reuptake inhibitor poisoning. UpToDate. 2018. doi: https://www.uptodate.com/ contents/selective-serotonin-reuptake-inhibitorpoisoning

  9. Grant F Brady MF. Serotonin Syndrome. Ferri’s Clinical Advisor Elsevier. 2019;1245-1246.

  10. Kleintjes W Kenny A. Serotonin syndrome in burns patients. S Afr J Surg. 2018; 56. doi: http:// dx.doi.org/10.17159/2078-5151/2018/v56n3a2456

  11. Manu P. Medical Consultation in Psychiatry: Serotonin Syndrome. Goldman-Cecil Medicine, Twenty-Fifth Edition, Elsevier. 2016; 434: 2625-2629.

  12. Marschall KE Hines RL. Psychiatric Disease, Substance Abuse, and Drug Overdose. Stoelting’s Anesthesia and Co-Existing Disease, Elsevier. 2018; 29: 611-633.

  13. Orlova Y Rizzoli P Loder E. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome. JAMA Neurol. 2018; 75: 566-572. doi:10.1001/jamaneurol.2017.5144

  14. Garcia E Santos C. Monoamine Oxidase Inhibitor Toxicity. National Center for Biotechnology Information StatPearls Publishing. 2019; doi: https:// www.ncbi.nlm.nih.gov/books/NBK459386/

  15. 15.Cargnel EG Cardosoa PC Irigoyena J Sol García Puglisia S. Un diagnóstico no pensado: toxicidad serotoninérgica secundaria a interacción medicamentosa. Caso clínico. Archivos argentinos de pediatría Sociedad Argentina de Pediatría. 2018; doi: http://dx.doi.org/10.5546/aap.2018.e115

  16. Meehan TJ. Approach to the Poisoned Patient. Rosen’s Emergency Medicine: Concepts and Clinical Practice Elsevier. 2018; 139: 1813-1822.

  17. Wiener Kronish, JP Fleisher LA (2016). Overview of Anesthesia. Goldman-Cecil Medicine, Twenty- Fifth Edition Elsevier. 2016; 432: 2617-2620.




2020     |     www.medigraphic.com